Meningococcal B vaccine may protect against gonorrhoea

With some strains of the common STI now resistant to all available drugs, the discovery provides new hope for a vaccine A retrospective case-control study of more than 14,000 New Zealanders aged 15-30 has found exposure to the meningococcal group B vaccine was associated with reduced likelihood of contracting gonorrhoea, compared with unvaccinated people. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Sanofi reassures on vaccine availability